CD34 Archives - MaxCyte

Off-Target Effects of CRISPR-Cas9 Gene Editing in Human Hematopoietic Stem and Progenitor Cells
Gallery
Off-Target Effects of CRISPR-Cas9 Gene Editing in Human Hematopoietic Stem and Progenitor Cells

Off-Target Effects of CRISPR-Cas9 Gene Editing in Human Hematopoietic Stem and Progenitor Cells

St Jones2022-08-10T16:01:11+00:00August 10th, 2022|Comments Off

Hematopoietic Stem Cell Electroporation for HDR-Mediated Correction of an X-Linked Blood Disorder
Gallery
Hematopoietic Stem Cell Electroporation for HDR-Mediated Correction of an X-Linked Blood Disorder

Hematopoietic Stem Cell Electroporation for HDR-Mediated Correction of an X-Linked Blood Disorder

St Jones2022-08-10T15:54:57+00:00August 10th, 2022|Comments Off

Which industry partner should I collaborate with? A scientists’ journey to implementing an innovative technology
Gallery
Which industry partner should I collaborate with? A scientists’ journey to implementing an innovative technology

Which industry partner should I collaborate with? A scientists’ journey to implementing an innovative technology

St Jones2022-06-06T21:59:54+00:00June 3rd, 2022|Comments Off

Ex Vivo Gene Correction in X-CGD Patient Stem Cells
Gallery
Ex Vivo Gene Correction in X-CGD Patient Stem Cells

Ex Vivo Gene Correction in X-CGD Patient Stem Cells

St Jones2022-06-24T21:45:19+00:00April 25th, 2022|Comments Off

Boosting the Efficacy of Tumor Infiltrating Lymphocytes via PD-1 Gene Editing
Gallery
Boosting the Efficacy of Tumor Infiltrating Lymphocytes via PD-1 Gene Editing

Boosting the Efficacy of Tumor Infiltrating Lymphocytes via PD-1 Gene Editing

ali2022-04-26T05:13:06+00:00May 16th, 2020|Comments Off

CRISPR-mediated Mutation Correction of Hematopoietic Stem Cells from Patients with X-linked Chronic Granulomatous Disease Using Non-Viral Cell Engineering
Gallery
CRISPR-mediated Mutation Correction of Hematopoietic Stem Cells from Patients with X-linked Chronic Granulomatous Disease Using Non-Viral Cell Engineering

CRISPR-mediated Mutation Correction of Hematopoietic Stem Cells from Patients with X-linked Chronic Granulomatous Disease Using Non-Viral Cell Engineering

ali2021-10-12T18:45:49+00:00May 16th, 2020|Comments Off

Improving NK Cell-based Cancer Immunotherapy via mRNA Electroporation
Gallery
Improving NK Cell-based Cancer Immunotherapy via mRNA Electroporation

Improving NK Cell-based Cancer Immunotherapy via mRNA Electroporation

ali2021-10-12T18:47:30+00:00May 16th, 2020|0 Comments

Translation of NK Cell CAR Therapy to the Clinic: Critical Role of Performance & Clinical-scalability
Gallery
Translation of NK Cell CAR Therapy to the Clinic: Critical Role of Performance & Clinical-scalability

Translation of NK Cell CAR Therapy to the Clinic: Critical Role of Performance & Clinical-scalability

ali2022-04-26T05:10:55+00:00May 16th, 2020|Comments Off

Advancing a CCR5 Gene Editing Therapy to Clinical Trial: Overcoming Viral Vector Toxicity
Gallery
Advancing a CCR5 Gene Editing Therapy to Clinical Trial: Overcoming Viral Vector Toxicity

Advancing a CCR5 Gene Editing Therapy to Clinical Trial: Overcoming Viral Vector Toxicity

ali2022-04-26T05:12:05+00:00May 15th, 2020|Comments Off

Engineering NK Cells with High-Affinity CD16 for Enhanced Combination Therapy to Treat B-Cell Lymphoma
Gallery
Engineering NK Cells with High-Affinity CD16 for Enhanced Combination Therapy to Treat B-Cell Lymphoma

Engineering NK Cells with High-Affinity CD16 for Enhanced Combination Therapy to Treat B-Cell Lymphoma

ali2022-04-25T21:31:31+00:00May 15th, 2020|Comments Off

Web Analytics Made Easy -
StatCounter